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Objective: Harvesting osteochondral grafts results in a zone of chondrocyte death (ZCD) in and around the
periphery of the graft, creating a barrier for chondrocytes to migrate to the graft periphery, thus limiting
cartilage-to-cartilage healing. The purpose of this study was to repopulate the induced ZCD through the
combined effects of collagenase treatment and delivery of a chemotactic agent.
Design: In bovine cartilage, the ZCD induced by the OATS osteochondral harvesting system was deter-
mined, followed by a corresponding collagenase treatment to penetrate the developed ZCD. The chemo-
tactic potential of platelet derived growth factor (PDGF-bb), insulin-like growth factor I (IGF-I), and basic
ﬁbroblast growth factor (bFGF) (2.5e100 ng/mL) was then assessed using a modiﬁed Boyden chamber
assay to select an appropriate agent to induce chondrocyte migration. Afterwards, the combined effects of
collagenase treatment and chondrocyte chemotaxis on the repopulation of an induced ZCD were examined
in cartilage explants over a 4-week-period.
Results: The OATS osteochondral harvesting system induced a signiﬁcant ZCD (173 mm, 95% CI:
[72e274 mm]) in the grafts. Chondrocyte chemotaxis was induced by all agents investigated at concen-
trations greater than 25 ng/mL. After 4 weeks in culture, collagenase treatment alone reduced the ZCD by
approximately 40% relative to untreated explants. Coupling the collagenase treatment with 25 ng/mL
IGF-I reduced the ZCD by approximately 80% relative to untreated explants, and 65% relative to explants
treated only with collagenase.
Conclusion: Treating cartilage explants with collagenase and 25 ng/mL IGF-I resulted in a decreased ZCD
after a 4-week-period, and increased chondrocyte density within the induced ZCD.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Mosaic arthroplasty, or osteochondral transfer, is a cartilage repair
strategy that aims to restore the articulating surface in a joint where
a chondral and/or osteochondral defect has occurred. This procedure
involves the transplantation of healthy, unaffected osteochondral
tissue from non-weight bearing regions of the joint into the defect
region that has beenprepared for graft insertion1. Themain beneﬁt of
mosaic arthroplasty is that it immediately results in ﬁlling of the
defect region with high-quality hyaline cartilage resulting in good
clinical outcomes. In a review of 789 procedures involving osteo-
chondral transfer in the knee, Hangody et al.2 reported good-to-to: Stephen D. Waldman,
of Mechanical and Materials
versity, Kingston, Ontario K7L
aldman).
s Research Society International. Pexcellent clinical results in 92% of patients. Similarly, in a consecutive
series of 52 patients, Jakob et al.3 reported improved knee function in
86% of patients at 2 years post-op.
Despite the relatively good clinical outcomes, some of the major
disadvantages of this procedure are donor site morbidity4,5 and the
general inability of the chondral portions of the transplanted grafts to
integrate with the surrounding host cartilage following insertion6.
This lack of integration can ultimately affect long-term outcomes in
patients who have undergone mosaic arthroplasty, as gaps between
grafts may serve as starting points for cartilage degeneration over
time7. This effect has been attributed to the zone of chondrocyte
death (ZCD) that is generated upon graft harvesting6, which gener-
ates a regionof dead tissue followingosteochondral graft harvest. The
ZCD creates a barrier (extending up to 390 mm into the tissue6) that
the chondrocytesmustmigrate through in order to populate the graft
periphery for effective cartilage integration to occur8. The lack of
chondrocyte migration through this region has been thought to be
inhibited by the dense extracellular matrix (ECM) of cartilage9. For
this reason, several studies have investigated the effect ofublished by Elsevier Ltd. All rights reserved.
Fig. 1. The extent of the ZCD was determined by measuring the distance from the
tissue periphery to the inner region of live cells at several points around each sample.
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tion, such as: chondroitinase ABC9,10, trypsin9, collagenase9,11 and
hyaluronidase9,11,12, and various combinations of these enzymes12e14.
Of these enzymatic treatments, only collagenase has been shown to
improve chondrocyte migration9,12. However, while chondrocyte
migration is facilitated in cartilage treated with collagenase, this has
only been demonstrated in cartilage manipulated with sharp scalpel
blades or biopsy punches, which do not induce a signiﬁcant ZCD
relative to an osteochondral harvesting instrument6,15. Thus, it is
unknown whether chondrocytes are able to migrate through the
signiﬁcant region of acellular cartilage that constitutes the ZCD
following a collagenase treatment. Furthermore, the extent to which
collagenase is able to penetrate into cartilage relative to the induced
ZCD has yet to be investigated.
Chondrocyte migration within cartilage may be facilitated with
chemotactic agents. Recently, chondrocyte chemotaxis has been
demonstrated in response to several growth factors, including:
insulin-like growth factor I (IGF-I)16, platelet derived growth factor
(PDGF-bb)17e19, and basic ﬁbroblast growth factor (bFGF)20,21.
However, no previous study has yet looked speciﬁcally at inducing
chondrocyte chemotaxis within cartilaginous tissue. Thus, the
purpose of this studywas to repopulate the induced ZCD through the
combined effects of collagenase treatment and delivery of a chemo-
tactic agent.
Materials and methods
Determination of the ZCD
Bovine articular cartilage and bone were harvested from the
metacarpal-phalangeal joints of 18 to 24-month-old calves obtained
from a local abattoir after slaughter (Brian Quinn’s Meats Ltd., Yarker,
ON, Canada). Cartilagewas trimmedusingeithera sharp 3 mmbiopsy
punch (Miltex Inc., York, PA, USA) to simulate scalpel manipulation of
cartilage tissue, or the OATS osteochondral harvesting system
(Arthrex Inc., Naples, FL, USA) to simulate surgical manipulation of
the cartilage. The cartilage explants were cultured in Ham’s F12
media supplemented with 1 insulin-transferrin-selenium (ITSþ;
SigmaeAldrich Ltd, Oakville, ON, Canada), 20 mM N-2-hydrox-
yethylpiperazine-N0-ethanesulfonic acid (HEPES; SigmaeAldrich
Ltd), and antibiotics/antimicotics (100 U/mL penicillin, 100 ug/mL
streptomycin, and 0.25 mg/mL amphotericin B; Invitrogen Canada
Inc., Burlington, ON, Canada) at 37C with 5% CO2 and 95% relative
humidity. Explants were cultured for 1 week, with media changed
three timesperweek. Following thecultureperiod, cell viability in the
tissues was assessed by using the LIVE/DEAD staining kit (Invi-
trogen Canada Inc.) and viewing under a multiphoton confocal
microscope (Leica TCS SP2 with Leica Image Pro Plus software; Leica
Microsystems GmbH, Wetzlar, Germany) at 40 magniﬁcation.
Images were taken at various depths through each tissue sample and
images were overlaid to create a projection through the entire depth
of the tissue. The extent of the ZCDwas determined bymeasuring the
minimum distance from the wound edge at the tissue periphery to
the inner region of tissue that contained the ﬁrst instance of live
chondrocytes. Ten measurements were made for each projected
image obtained at approximately 50 mm increments along the cut
surface, which were then averaged together to quantify the ZCD
(Fig. 1).
Collagenase degradation of the periphery of the cartilage explant
Different collagenase treatments were investigated in order to
determine the extent of penetration into the tissue. Cartilage
explant tissue was harvested, as described previously, and trim-
med into 3 mm diameter cylindrical sections using either a biopsypunch or the OATS osteochondral harvesting system. Explants
were treated with 0.15%, 0.3%, or 0.6% collagenase A (source:
Clostridium histolyticum; Roche Diagnostics Canada, Laval, QC,
Canada) for varying amounts of time (2.5e60 min). Following
treatment, the samples were washed thoroughly three times in
phosphate buffered saline (PBS) and ﬁxed in 4% paraformaldehyde.
The samples were then embedded in parafﬁn, cut into 5 mm thick
sections, and stained with picrosirius red to reveal intact and
degraded collagen22. Each sample was viewed under light
microscopy at 40magniﬁcation, and the depth of the collagenase
penetration into the tissue was determined by measuring the
distance from the periphery of the tissue to the region of degraded
collagen within the tissue with the use of ImageJ software (US
National Institutes of Health, Bethesda, MD, USA)23.
Boyden chamber assays
Primary bovine articular chondrocytes (from the metacarpal-
phalangeal joints of 18 to 24-month-old calves) were isolated by
sequential enzymatic digestion, as described previously24. Chon-
drocyte chemotaxiswasmeasuredusing amodiﬁedBoyden chamber
assay19,20. Brieﬂy, 6.5 mm diameter polycarbonate ﬁlters with 8 mm
pores, (Corning Costar, Lowell, MA, USA) separated the cells seeded
on the upper side of the membranes from the chemotactic agent on
the underside of themembranes. Prior to cell seeding, the upper and
lower compartments were incubated in Ham’s F12 media with 0.1%
bovine serum albumin (BSA, SigmaeAldrich Ltd.) at 37C for 2 h to
removenonspeciﬁc proteinbinding sites. The lowercompartments of
theﬁlters were then ﬁlledwithHam’s F12media supplementedwith
PDGF-bb, IGF-I, or bFGF (2.5e100 ng/mL; Peprotech Inc., Rocky Hill,
NJ, USA), 0.1% BSA, 20 mM HEPES, and antibiotics/antimicotics. The
upper compartments were ﬁlled with 2105 isolated chondrocytes
suspended in Ham’s F12media supplemented with 0.1% BSA, 20mM
HEPES, and antibiotics/antimicotics. Cultures were placed in an
incubatormaintained at 37Cwith 5%CO2 and 95% relative humidity.
After 24 h, chondrocytes remaining on the upper side of the
membranes were removed using a cotton swab. Chondrocytes that
migrated to the underside of the membrane were ﬁxed in methanol
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Chondrocyte migration was assessed by counting the number of
chondrocytes in six random 0.5 mm2 ﬁelds on the underside of each
membrane using an inverted light microscope (HundWetzlar model
Wilovert S;Wetzlar, Germany) with a mounted Leica camera (model
DFC320) and ImageJ software23 at 100 magniﬁcation. The average
cell counts on the underside of the membrane for each group were
normalized to the average cell count on the underside of the
membrane for the growth factor-free control group.Chondrocyte repopulation of the zone of death
Bovine cartilage explant tissue was harvested as described
previously. Fresh 3 mm biopsy punches were dulled with the aid of
a wooden block so that a ZCD would be generated that is similar to
the zone of death that is induced by an osteochondral harvesting
instrument6. This was done to obtain cartilage samples without
underlying subchondral bone as the presence of bone would
interfere with the confocal imaging to be conducted on these
samples to assess the effect of various treatments to repopulate the
ZCD.
Each sample was then assigned to one of the following groups:
(1) optimal collagenase treatment to penetrate the ZCD prior to
the culture period, (2) optimal collagenase treatment prior to the
culture period and delivery of chemotactic agents (PDGF-bb, IGF-I,
or bFGF) during the culture period at the optimal concentration
to elicit migration, (3) control group with no treatment, or
(4) control group with no treatment to be harvested after 10 days
(to conﬁrm the extent of the initially induced ZCD which has been
shown to take up to 10 days to form25). All samples (with the
exception of group (4), as noted previously) were cultured for
a period of 4 weeks in Ham’s F12 media supplemented with
1 ITS, 20 mMHEPES and antibiotics/antimicotics at 37Cwith 5%
CO2 and 95% relative humidity. Following the culture period,
samples were treated with the LIVE/DEAD staining kit and
viewed under a Leica TCS SP2 multiphoton confocal inverted
microscope with Leica Image Pro Plus software at 40 magniﬁ-
cation. Images were taken at various depths, parallel to the
articular surface (at approximately 50 mm steps), through each
tissue sample and images were overlaid to create a projection
through the entire depth of the tissue. The extent of the ZCD was
determined as described previously. The cellular repopulation of
the ZCD was semi-quantiﬁed by counting the number of live cells
within the induced ZCD region of each sample (in the entire
overlaid image) normalized to the cellularity of healthy tissue
using ImageJ software23.Statistical analyses
For experiments involving harvested cartilage or isolated
chondrocytes, samples were obtained from a pooled source of
dissected legs to reduce inter-animal variability. All numerical
results were expressed as a mean 95% conﬁdence interval for the
mean (95% CI). Experimental and control groups from different
conditions were statistically compared using a one-way analysis of
variance (ANOVA) with comparisons between individual experi-
mental groups (growth factor concentration, etc.) assessed using
Bonferroni-corrected independent sample, post-hoc t-tests. All
datasets were checked prior to performing statistical tests for both
normality and equal-variance with none of the datasets failing
either test. Signiﬁcance was associated with P-values less than 0.05
and trends were associated with P-values between 0.05 and 0.1. All
statistical tests were conducted using SPSS statistical software
(SPSS version 16, SPSS Inc., Chicago, IL, USA).Results
Determination of the ZCD
The extent of the ZCD in tissue samples harvested with
the OATS osteochondral harvesting system (173 mm, 95%
CI: [72e274 mm], n¼ 5) was signiﬁcantly greater than the extent of
the ZCD in samples harvested using a biopsy punch (26 mm, 95%
CI: [8e44 mm], n¼ 5) (P< 0.001).
Collagenase degradation of the periphery of the cartilage explant
When the OATS osteochondral harvesting system was used to
harvest the explant tissue, collagenase penetration into the tissue
appeared to predominantly progress as a linear front [Fig. 2(A, C, E)].
Conversely, when the explant tissue was harvested using a sharp
biopsy punch, collagenase penetration was dependent on the
distance from the articular surface of the explants and decreased in
a monotonic fashion away from the tissue surface [Fig. 2(B, D, F)].
Regardless of harvesting method, longer treatment times [Fig. 2(C
and D)] and higher collagenase concentrations [Fig. 2(E and F)]
resulted in greater collagenase penetration into the explants. The
optimal collagenase treatment to be used in all subsequent experi-
ments was selected as 0.6% for 10 min as this resulted in the depth of
penetration of approximately 175 mm, which corresponded to the
extent of the ZCD induced by the OATS osteochondral harvesting
system observed previously.
Boyden chamber assays
Using a modiﬁed Boyden chamber assay, the chemotactic
response of chondrocytes to PDGF-bb, bGFG, and IGF-I was assessed
over awide concentration range (2.5e100 ng/mL). In response to the
growth factors, increased chondrocyte chemotaxis towards PDGF-bb,
bFGF, and IGF-I was observed at a concentration of 25 ng/mL
(P< 0.02), with no differential effects observed between growth
factors (Fig. 3). Similarly, at concentrationsabove25 ng/mL, therewas
no additional effect on chondrocyte chemotaxis for any of the growth
factors investigated. For this reason, a growth factor concentration of
25 ng/mL was used to promote chondrocyte chemotaxis in all
subsequent experiments.
Overcoming the ZCD
Harvested bovine cartilage explants were maintained in vitro for
a period of 4 weeks with or without treatment with collagenase or
chemotactic agents (Fig. 4). Throughout the culture period, no
chondrocyteswere observed resident at theperipheryof the explants
or growing on the bottom of the culture dish. In the untreated
explants, the induced ZCD was 179 mm (95% CI: [67e291 mm], n¼ 5)
following 10 days in culture and did not signiﬁcantly change
throughout the 4-week-culture period (ZCD at 4weeks: 175 mm (95%
CI: [82e268 mm],n¼ 5)) (Fig. 5).However, eachof the treatmentshad
a signiﬁcant effect on reducing the ZCD relative to the untreated
(control) explants (P< 0.02, n¼ 5). Explants treatedwith collagenase
and supplementedwith bFGF or PDGF-bb did not have a signiﬁcantly
reduced ZCD relative to the collagenase-only treated group (P¼ 0.2,
n¼ 5) (Fig. 5). Alternatively, explants treated with collagenase and
IGF-I had a signiﬁcantly reduced ZCD relative to the collagenase-only
treated group (P< 0.001, n¼ 5).
The cellularity within the ZCD region following 4 weeks in
culture was signiﬁcantly higher in all treatment groups relative to
the untreated (control) explants (P< 0.001, n¼ 5) (Fig. 6). Explants
treated with collagenase and bFGF or PDFG-bb did not have
a signiﬁcantly increased cellularity relative to the collagenase-only
Fig. 2. Collagenase penetration into the wound edge of bovine articular cartilage harvested using either the osteochondral autograft transfer system (OATS) (A, C, E), or a sharp
biopsy punch (B, D, F). In sections stained with picrosirius red (A, B), the more intensely-stained regions (indicated by arrows) indicate the depth to which collagenase penetrated
into the tissue following 30 min treatment with 0.15% collagenase (magniﬁcation 40, scale bar¼ 100 mm). The effect of collagenase treatment time (C, D) was assessed at
a concentration of 0.15% and the effect of collagenase concentration (E, F) was assessed after an exposure time of 10 min.
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with collagenase and IGF-I had a signiﬁcantly increased cellularity
relative to the collagenase-only treated group (P< 0.03, n¼ 5).
Discussion
The purpose of this study was to investigate the combined
effects of collagenase treatment and chemotactic agents on the
repopulation of the induced ZCD created during osteochondral
harvesting. Previous studies have found a signiﬁcant effect of the
harvesting tools on cell death in areas adjacent to the wound edge.
In one study, the ZCD created using a surgical osteotomewas on the
order of 390 mm, whereas a scalpel harvesting resulted in a ZCD ofapproximately 35 mm6. Another study, while not explicitly
measuring the induced ZCD, found that cartilage harvested with
a blunt instrument resulted in signiﬁcant cell death at the wound
edge, whereas cartilage harvested with a sharp scalpel did not15.
Some effort has been placed on redesigning osteochondral har-
vesting tools to minimize the induced ZCD26. In this study, while
the geometry of the cutting-tip can inﬂuence the ZCD, the
improved design produced a ZCD of around 120 mm. The results of
the present study conﬁrm these ﬁndings with osteochondral har-
vesting tools resulting in signiﬁcant cell death adjacent to the
wound edge and scalpel harvesting resulting in little cell death.
In order to promote chondrocyte outgrowth from cartilage9 or to
increase chondrocyte density at the periphery of cartilage11,12,14,
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Fig. 3. Chemotaxis dose response of bovine articular chondrocytes to IGF-I, PDGF-bb,
and bFGF normalized to non-supplemented controls. Data expressed as meanwith 95%
CIs (n¼ 3). * Signiﬁcantly different than control (P< 0.02).
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enzymes. While pre-treatment with collagenase can be effective to
promote chondrocyte migration to the wound edge, the penetration
proﬁle into the tissue has not been examined in detail. It is important
not to over-treat the tissue as it may degrade more ECM than is
necessary, potentially resulting in decreased structural integrity of
the osteochondral core. For this reason, in this study we tailored the
collagenase treatment to only penetrate the induced ZCD to preserve
the structural integrity of the remainder of the explant. One unex-
pected ﬁnding here was that the extent of collagenase penetration
appeared to be dependent on the method of harvest. When the
explant was harvested with a sharp biopsy punch, the depth of
collagenase penetration appeared to be greatest at the articularFig. 4. Confocal images of the effect of various treatments on the repopulation of the ZCD. (A
culture: (B) untreated (control), (C) collagenase treatment only (0.6% for 10 min), (D) collagen
and (F) collagenase treatment and IGF-1 (25 ng/mL). Magniﬁcation of 40; scale bar¼ 200 msurface and decreased in amonotonic fashion towards the deep zone
of the tissue. However, extracting cartilage explants using the OATS
osteochondral harvesting created a near uniform depth of penetra-
tion throughout the thickness of the explant. While the effect on
cartilage-to-cartilage healing following osteochondral implantation
was not investigated here, this ﬁnding may have signiﬁcant impli-
cations on subsequent tissue integration upon transplantation. The
development of a uniform front of outgrowing chondrocytes
throughout the thickness of the explant would potentially lead to
better integration into the surrounding host cartilage. Additionally,
as deep zone chondrocytes are primarily responsible for generating
cartilaginous ECM following outgrowth from cartilage explants27, the
penetration of this zone by collagenase after use of an osteochondral
harvesting tool would facilitate deep zone chondrocytes to migrate
to the tissue periphery and potentially ensure a better healing
response. It should be noted that the method used to semi-quantify
the depth of collagenase penetration was assessed through histo-
logical staining. While picrosirius red is effective at staining both
intact and degraded collagen22, there are some limitations of this
approach. Staining intensity can also reﬂect changes in collagen ﬁbre
density. Moreover, the potential loss of glycosaminoglycans from the
tissue as a result of collagenase digestion could also potentially lead
to more effective collagen staining (due to an unmasking effect).
These limitations aside, comparison of the staining between
harvesting techniques suggests that the OATS osteochondral har-
vesting system results in a more uniform depth of penetration into
the tissue, potentially leading to improved chondrocyte migration
towards the wound edge.
In this study, the same chemotactic response was observed in
response to each of the growth factors investigated (IGF-I, PDGF-bb,
and bFGF) at the same relative concentrations. While there have) Initial ZCD after 10 days of culture compared to different treatments after 4 weeks of
ase treatment and PDGF-bb (25 ng/mL), (E) collagenase treatment and bFGF (25 ng/mL),
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Fig. 5. ZCD measured from the cut surface of bovine articular cartilage explants
following a 10-minute treatment with 0.6% collagenase, or collagenaseþ a chemotactic
growth factor (PDGF-bb, bFGF, or IGF-I) at 25 ng/mL. Data expressed as mean with 95%
CIs (n¼ 5). * Signiﬁcantly different than control (P< 0.02); ** Signiﬁcantly different
than collagenase-only treatment (P< 0.001).
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to growth factors16e21, there appears to a wide variability in the
observed response to these agents. For example, Chang et al.16 found
10 ng/mL IGF-I elicited a two-fold increase in chondrocyte chemo-
taxis, whereas in the present study, no chemotactic effect was
observed at this concentration. Similarly, Maniwa et al.21 observed
that bFGF at concentrations greater than 1 ng/mL signiﬁcantly
induced more chondrocyte chemotaxis than lower concentrations,
whereas higher threshold responses were observed both in the
present study (25 ng/mL) and that by Hidaka et al.20 (5 ng/mL). In
contrast, the only agreement between studies was observed in
response to PDGF-bb. Mishima et al.19 observed an approximate 60%
improvement in chondrocyte chemotaxis at 50 ng/mL PDGF-bb,
which is comparable to the present study, in which 50 ng/mL PDGF-
bb resulted in approximately 45% more chemotaxis relative to
control. While the reason for this wide discrepancy in published
results is not explicitly known, there are several potential factors,
most notably the difference in species, cell type (primary cells,
passage cells or immortalized cell lines) and methodological differ-
ences between the studies (e.g., Boyden chambers coatings, time-
frame allowed for chemotaxis). Such differences highlight the need
for a standardized method for determining chondrocyte chemotaxis
to ensure the comparison of results in future studies.0
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Fig. 6. Cellularity within the initially induced ZCD following 4 weeks in culture,
normalized to the cellularity of healthy tissue. Data expressed as mean with 95% CIs
(n¼ 5). * Signiﬁcantly different than control (P< 0.04); ** Signiﬁcantly different than
collagenase-only treatment (P< 0.003).Long-term culture of harvested bovine cartilage explants pre-
treated with collagenase in the presence of chemotactic agents
resulted in signiﬁcant repopulation of the induced ZCD by chon-
drocytes. This effect was most notable with IGF-I as opposed to
either bFGF or PDGF-bb. While it is presently unknown why long-
term treatment with IGF-I resulted in a greater degree of ZCD
repopulation relative to the other chemotactic growth factors
investigated, there may be potential differences in cell proliferation
in response to growth factor stimulation over the long-term that
could also inﬂuence the extent of ZCD repopulation. Irrespective of
the exact mechanism of ZCD repopulation, this ﬁnding has signif-
icant implications to osteochondral transfer as the ZCD represents
an area of what is essentially dead cartilage that may disintegrate
over time28. However, by increasing the cellularity within this
region of dead cartilage, the viability may be restored, thus allow-
ing the tissue to remain healthy and potentially leading to better
long-term clinical outcomes. Another implication of this work is
that if chondrocyte migration into the ZCD continues beyond 4
weeks, it may be possible to encourage the chondrocytes to migrate
beyond the periphery of the tissue. Outgrown chondrocytes could
have the potential to facilitate cartilage-to-cartilage healing, or ﬁll
the gap regions between osteochondral grafts following mosaic
arthroplasty with hyaline cartilage. In order to allow for such
migration to occur in vivo, an appropriate growth factor delivery
vehicle must be developed that can deliver a chemotactic agent so
that chemotaxis can be sustained.
In this study, it has been demonstrated that chondrocytes are
able to repopulate the ZCD induced upon osteochondral harvest
following a brief collagenase treatment and supplementation with
IGF-I. Clinical implications of ZCD repopulation are the increased
long-term viability of the cartilaginous portions of osteochondral
grafts and potential to facilitate integration between grafts and
surrounding tissue. However, the efﬁcacy of this approach requires
a sustained delivery of chemotactic agents, thus requiring the
development of a suitable delivery vehicle which is the focus of our
continuing research in this area.Author contributions
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